Methods for Accommodating Nonproportional Hazards in Clinical Trials: Ready for the Primary Analysis?
Author:
Affiliation:
1. National Cancer Institute, Bethesda, MD
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.19.01681
Reference57 articles.
1. How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy?
2. Nivolumab in Nonsquamous Non–Small-Cell Lung Cancer
3. Neratinib after trastuzumab in patients with HER2-positive breast cancer
4. Neratinib after trastuzumab in patients with HER2-positive breast cancer – Author's reply
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluation of the proportional hazards assumption and covariate adjustment methods in comparative surgical observational studies with time-to-event endpoints;European Journal of Surgical Oncology;2024-09
2. Comparison between asymptotic and re-randomisation tests under non-proportional hazards in a randomised controlled trial using the minimisation method;BMC Medical Research Methodology;2024-07-30
3. Exploratory subgroup identification in the heterogeneous Cox model: A relatively simple procedure;Statistics in Medicine;2024-07
4. Scaling and interpreting treatment effects in clinical trials using restricted mean survival time;Clinical Trials;2024-06-13
5. Group sequential methods based on supremum logrank statistics under proportional and nonproportional hazards;Statistical Methods in Medical Research;2024-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3